Stockreport

AzurRx BioPharma Announces Presentation on Its Positive Phase II Data in MS1819-SD in Chronic Pancreatitis at the 2019 Digestive Disease Week Conference

AzurRx BioPharma, Inc.  (AZRX) 
Last azurrx biopharma, inc. earnings: 11/14 04:31 pm Check Earnings Report
PDF NEW YORK, March 18, 2019 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemi [Read more]